Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PEX16 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC644172 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAPK8IP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRY2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC35C1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PHF21A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CHST1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CREB3L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DGKZ - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MDK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CHRM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AMBRA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SYT13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRDM11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TP53I11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on